Resultados financieros en millones de dólares estadounidenses. El ejercicio fiscal es febrero - enero.
Breakdown
TTM
03/31/2025
03/31/2024
03/31/2023
03/31/2022
03/31/2021
Ingresos
2,422,069
2,399,952
2,386,493
2,314,828
2,239,112
2,128,218
Crecimiento de los Ingresos (YoY)
1%
1%
3%
3%
5%
-4%
Costo de los ingresos
2,230,813
2,207,720
2,201,244
2,135,133
2,071,780
1,970,637
Utilidad bruta
191,256
192,232
185,249
179,695
167,332
157,581
Venta, General y Administración
154,274
151,583
147,094
144,137
142,624
145,230
Investigación y Desarrollo
--
3,523
3,279
2,952
4,592
3,453
Gastos de Operación
154,274
155,107
150,374
147,090
147,216
148,425
Otras Ingresos (Gastos) No Operativos
984
813
764
1,067
891
7,899
Ingreso antes de impuestos
44,548
50,287
42,793
30,594
22,484
12,557
Gasto por Impuesto a la Renta
14,082
15,783
13,793
10,275
8,012
4,559
Ingreso Neto
30,459
34,496
29,016
20,345
14,393
7,895
Crecimiento de la Utilidad Neta
-9%
19%
43%
41%
82%
-72%
Acciones en Circulación (Diluidas)
70.55
75.88
81.07
86.03
88.2
89.19
Cambio de Acciones (YoY)
-9%
-6%
-6%
-2%
-1%
-2%
EPS (Diluido)
431.73
454.57
357.87
236.46
163.18
88.51
Crecimiento de EPS
0%
27%
51%
45%
84%
-71%
Flujo de efectivo libre
1,508
-83,726
71,577
19,527
-4,771
7,737
Flujo de efectivo libre por acción
--
--
--
--
--
--
Margen bruto
7.89%
8%
7.76%
7.76%
7.47%
7.4%
Margen de operación
1.52%
1.54%
1.46%
1.4%
0.89%
0.43%
Margen de beneficio
1.25%
1.43%
1.21%
0.87%
0.64%
0.37%
Margen de flujo de caja libre
0.06%
-3.48%
2.99%
0.84%
-0.21%
0.36%
EBITDA
49,117
49,178
43,438
41,244
29,676
19,335
Margen de EBITDA
2.02%
2.04%
1.82%
1.78%
1.32%
0.9%
D&A para EBITDA
12,135
12,053
8,563
8,639
9,560
10,179
EBIT
36,982
37,125
34,875
32,605
20,116
9,156
Margen de EBIT
1.52%
1.54%
1.46%
1.4%
0.89%
0.43%
Tasa de Impuesto Efectiva
31.61%
31.38%
32.23%
33.58%
35.63%
36.3%
Estadísticas clave
Cierre Anterior
$30.3
Precio de apertura
$30.3
Rango del día
$30.3 - $30.3
Rango de 52 semanas
$30.3 - $30.3
Volumen
100
Volumen promedio
0
EPS (TTM)
2.65
Rendimiento de dividendos
--
Cap. de mercado
$2.1B
¿Qué es SZUKF?
Suzuken Co., Ltd. engages in the pharmaceutical business. The company is headquartered in Nagoya, Aichi-Ken and currently employs 12,923 full-time employees. The firm operates in four business segments. The Pharmaceutical Wholesale segment sells pharmaceuticals, diagnostic drugs, and medical equipment and materials, among others. The Pharmaceutical Manufacturing segment manufactures pharmaceuticals and diagnostic drugs and others. The Insurance Pharmacy segment is engaged in dispensing operations based on prescriptions from medical institutions. The Medical-related Service and Others segment is engaged in the provision of manufacturer support services, such as the transportation of medicines and comprehensive support for the distribution of drugs for rare diseases; the nursing services; the manufacture of physiological examination equipment, such as electrocardiographic monitors and blood pressure monitors; as well as other services, such as the sale of medical books.